170895-2025 - Contract modification
Spain – Pharmaceutical products – Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
OJ S 53/2025 17/03/2025
Contract modification notice
Supplies
1. Buyer
1.1.
Buyer
Official nameOSAKIDETZA - Servicio Vasco de Salud - Organización Central
Emailcontrata@osakidetza.eus
2. Procedure
2.1.
Procedure
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
DescriptionSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Procedure identifiereead91cd-644f-49f1-9dc1-1443539a5b83
Internal identifier2021/02385
2.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
2.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
2.1.4.
General information
Legal basis
Directive 2014/24/EU
5. Lot
5.1.
LotLOT-0001
Title1 - INTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
DescriptionINTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Internal identifier1 - INTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0002
Title2 - INTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
DescriptionINTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Internal identifier2 - INTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0003
Title3 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
DescriptionLEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
Internal identifier3 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0004
Title4 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
DescriptionLEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
Internal identifier4 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0005
Title5 - TADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
DescriptionTADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
Internal identifier5 - TADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0006
Title6 - EFAVIRENZ (DOE)
DescriptionEFAVIRENZ (DOE)
Internal identifier6 - EFAVIRENZ (DOE)
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0007
Title7 - VALGANCICLOVIR (DOE) SOLUCIÓN ORAL
DescriptionVALGANCICLOVIR (DOE) SOLUCIÓN ORAL
Internal identifier7 - VALGANCICLOVIR (DOE) SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0008
Title8 - BUSULFANO (DOE)
DescriptionBUSULFANO (DOE)
Internal identifier8 - BUSULFANO (DOE)
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0009
Title9 - BORTEZOMIB (DOE)
DescriptionBORTEZOMIB (DOE)
Internal identifier9 - BORTEZOMIB (DOE)
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0010
Title10 - METADONA (DOE) SOLUCIÓN ORAL
DescriptionMETADONA (DOE) SOLUCIÓN ORAL
Internal identifier10 - METADONA (DOE) SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0011
Title11 - METADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
DescriptionMETADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
Internal identifier11 - METADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
LotLOT-0012
Title12 - FIBRINÓGENO HUMANO (DOE)
DescriptionFIBRINÓGENO HUMANO (DOE)
Internal identifier12 - FIBRINÓGENO HUMANO (DOE)
5.1.1.
Purpose
Main nature of the contractSupplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS)Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration1 Year
5.1.4.
Renewal
Maximum renewals0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA)yes
5.1.12.
Terms of procurement
Terms of contract
The execution of the contract must be performed within the framework of sheltered employment programmesNo
Electronic invoicingRequired
Electronic ordering will be usedno
Electronic payment will be usedno
5.1.16.
Further information, mediation and review
Review organisationÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedureOSAKIDETZA - Servicio Vasco de Salud - Organización Central
6. Results
Value of all contracts awarded in this notice1 804 832,00 EUR
6.1.
Result lot identifierLOT-0001
6.1.2.
Information about winners
Winner
Official nameBAYER HISPANIA S L
Tender
Tender identifier1189440
Identifier of lot or group of lotsLOT-0001
Value of the tender340 000,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00001
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0003
6.1.2.
Information about winners
Winner
Official nameBAYER HISPANIA S L
Tender
Tender identifier1189441
Identifier of lot or group of lotsLOT-0003
Value of the tender166 972,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00002
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0004
6.1.2.
Information about winners
Winner
Official nameGEDEONRICHTERIBERICA SAU
Tender
Tender identifier1189442
Identifier of lot or group of lotsLOT-0004
Value of the tender179 920,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00003
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0005
6.1.2.
Information about winners
Winner
Official nameACCORD HEALTHCARE, S.L.U.
Tender
Tender identifier1189443
Identifier of lot or group of lotsLOT-0005
Value of the tender11 550,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00004
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0008
6.1.2.
Information about winners
Winner
Official nameFRESENIUS KABI
Tender
Tender identifier1189444
Identifier of lot or group of lotsLOT-0008
Value of the tender55 200,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00005
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0009
6.1.2.
Information about winners
Winner
Official nameFRESENIUS KABI
Tender
Tender identifier1189445
Identifier of lot or group of lotsLOT-0009
Value of the tender37 590,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00006
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
6.1.
Result lot identifierLOT-0012
6.1.2.
Information about winners
Winner
Official nameOCTAPHARMA, S.A.
Tender
Tender identifier1189446
Identifier of lot or group of lotsLOT-0012
Value of the tender1 013 600,00 EUR
SubcontractingNo
Contract information
Identifier of the contract2021/02385252_00007
TitleSuministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract29/08/2022
7. Modification
7.1.
Modification
Identifier of the previous contract award notice524369-2024
Reason for modificationNeed for modifications because of circumstances which a diligent buyer could not predict.
DescriptionIncidencias contractuales 1: Fecha resolución: 2025-03-11+01:00. Importe: 0.
7.1.1.
Change
Description of modificationsIncidencias contractuales
Section identifierCON-0007
8. Organisations
8.1.
ORG-0001
Official nameÓrgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Registration number66221.0
Postal addressC/ Donostia-San Sebastián, 1
TownVitoria-Gasteiz
Postcode01010
CountrySpain
Emailoarc@euskadi.eus
Telephone+34 945018000
Internet addresshttp://www.ejgv.euskadi.eus
Roles of this organisation
Review organisation
8.1.
ORG-0003
Official nameOSAKIDETZA - Servicio Vasco de Salud - Organización Central
Registration numberS5100023J
Postal addressAlava, 45
TownVitoria-Gasteiz
Postcode01006
CountrySpain
Contact pointServicio de Farmacia
Emailcontrata@osakidetza.eus
Telephone+34 945006018
Internet addresshttp://www.osakidetza.euskadi.net
Roles of this organisation
Buyer
Organisation providing additional information about the procurement procedure
8.1.
ORG-0005
Official nameBAYER HISPANIA S L
Registration numberB08193013
Postal addressAvenida baix Llobregat, 3 -5
TownSant Joan Despí
Postcode08970
CountrySpain
Emaillicitaciones@bayer.com
Telephone+34 934956774
Fax+34 934956502
Roles of this organisation
Tenderer
Winner of these lotsLOT-0001, LOT-0003
8.1.
ORG-0007
Official nameGEDEONRICHTERIBERICA SAU
Registration numberA28679868
Postal addressPEDRO I PONS Nº 9
TownBarcelona
Postcode08034
CountrySpain
Emailjl.ibanez@gedeonrichter.es
Telephone+34 691815443
Roles of this organisation
Tenderer
Winner of these lotsLOT-0004
8.1.
ORG-0008
Official nameACCORD HEALTHCARE, S.L.U.
Registration numberB65112930
Postal address08039
TownBarcelona
Postcode08039
CountrySpain
Emailmmayolas@accord-healthcare.com
Telephone+34 933010064
Roles of this organisation
Tenderer
Winner of these lotsLOT-0005
8.1.
ORG-0009
Official nameFRESENIUS KABI
Registration numberA08130502
Postal addressMarina 16-18
TownBarcelona
Postcode08005
CountrySpain
Emailconcursos.spain@fresenius-kabi.com
Telephone+34 932256565
Roles of this organisation
Tenderer
Winner of these lotsLOT-0008, LOT-0009
8.1.
ORG-0011
Official nameOCTAPHARMA, S.A.
Registration numberA79198339
Postal addressAvda. Castilla, 2
TownSan Fernando de Henares
Postcode28830
CountrySpain
Emailnuria.lopez@octapharma.com
Telephone+34 916487298
Roles of this organisation
Tenderer
Winner of these lotsLOT-0012
Notice information
Notice identifier/version5a575e95-9268-45e9-856d-3a4129025199  -  03
Form typeContract modification
Notice typeContract modification notice
Notice subtype38
Notice dispatch date13/03/2025 16:00:04 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially availableSpanish
Notice publication number170895-2025
OJ S issue number53/2025
Publication date17/03/2025